Medical Director, Oncology CoE

Avance Clinical Pty; Sydney; Remote; AUD 250,000 - 350,000; Full time

Benefits offered by this job

Competitive salary package

Flexible work arrangements

Industry-leading technology

Job summary

Avance Clinical, a leading Australian CRO, is seeking an Australian-based Medical Director, Oncology. The role reports to the Executive Medical Director and sits within the Oncology Centre of Excellence, driving global oncology strategy for solid tumors in early- to mid-phase trials.

You will lead scientific leadership, build sponsor relationships, and influence project delivery with KOLs and investigators.

Qualifications

• MD or equivalent medical degree required.
• Oncology specialist qualifications or board certifications preferred.
• Experience in oncology clinical research in CRO/biotech environments.
• Fluent English, strong scientific communication.

Responsibilities

• Lead oncology strategy across all drug-development phases.

Skills

Oncology leadership

Client engagement

Business development

Team leadership

Scientific communication

Education

MD or equivalent medical degree

Oncology specialist qualification

Job description

In this newly created role we're seeking an Australian based Oncology Medical Director for our growing CRO business.

23rd October, 2026

Medical Director, Oncology Centre of Excellence, Australia

Join Frost & Sullivan's 2026 Global Company of the Year for Biotech CRO Leadership

Reporting to: Executive Medical Director, Oncology

Department: Oncology Centre of Excellence

At Avance Clinical, we're helping innovative biotech and pharmaceutical companies bring life-changing therapies to patients faster. Following significant growth and new global project wins, we're expanding our team and looking for a Medical Director, Oncology, to join our Oncology Centre of Excellence.

If you're passionate about clinical research, an oncology subject matter expert and enjoy working on complex studies, while collaborating with some of the world's most exciting biotech companies, we'd love to hear from you.

Why Join Avance Clinical?

Global Recognition: Work for the CRO recognised by Frost & Sullivan as the 2026 Global Company of the Year for excellence in biotech CRO leadership.

Work Remotely: Enjoy genuine flexibility and autonomy with a fully remote role supported by industry-leading technology and a highly collaborative culture.

Accelerate Your Career: Join one of Australia's fastest-growing CROs, where high performers are recognised and supported to advance their careers.

Meaningful, Diverse Projects: Be the SME on Early to Mid-Phase oncology clinical trials and work with emerging biotech companies developing the next generation of therapies.

The Opportunity

The Medical Director, Oncology is a significant medical leadership role responsible for shaping and executing Avance Clinical’s global oncology strategy across all phases of drug development, with a focus on solid tumors and early- to mid-phase trials. The role serves as a primary oncology subject matter expert (SME) for Avance and its clients, with the key objectives of:

• winning new oncology business through expert client engagement
• building / maintaining investigator and KOL relationships
• having a high-impact pre-award input to optimize project delivery strategies and optimal vendor recommendations, and
• differentiated scientific leadership.

The role provides strategic direction in oncology for Avance as a CRO and, on a project-specific basis, for each client, ensuring that oncology programs are medically robust, commercially competitive, locally feasible in the countries recommended for execution, and aligned with evolving global standards of care and regulatory expectations.

Additionally you’ll support business development activities by helping to identify and qualify oncology opportunities, contributing to proposals, RFIs/RFPs, and client meetings as a client-facing technical expert and commercial partner.

You’ll build and maintain relationships with biotechs, pharmaceutical companies, and key opinion leaders (KOLs), helping to position Avance’s Oncology Centre of Excellence as a preferred CRO partner across all regions of the globe.

You’ll also represent Avance at relevant oncology and clinical research conferences, contributing to presentations, panel discussions, and other scientific or commercial activities that enhance Avance’s brand.

What We're Looking For

• Medical degree (MD or equivalent) is required. Specialist qualification, board certifications, or equivalent recognition in oncology or an oncology-related discipline.
• Significant experience in oncology clinical research, preferably including roles within biotechnology and/or CRO environments where you have a strong understanding of local operational & regulatory requirements.
• Demonstrated success in client-facing, commercial or business development-oriented roles, combining deep technical expertise with the ability to influence, persuade, and "sell" solutions to sponsors.
• Experience attending and contributing to oncology or clinical research conferences.
• Oral & written fluency in English with the ability to discuss complex medical & scientific concepts & clinical research topics.
• The ability and willingness to work in a matrixed team environment, providing guidance and medical training to teams.
• Possess positive relationships with oncologists and assist with growing Avance’s database of institutions/investigators/KOLs/site networks, with whom clinical trials are conducted. The ability to thrive in a fast-paced, growing CRO environment.
• Able to travel globally for conferences, client meetings and industry events.

What You'll Receive

• Competitive salary package
• Flexible work arrangements
• Industry-leading technology and systems
• Diverse, intellectually stimulating projects
• Clear career progression opportunities
• Supportive leadership team and collaborative culture
• Long-term stability with a growing global CRO

About Avance Clinical

Avance Clinical is a leading Australian CRO providing specialised drug development services to the biotechnology and pharmaceutical industries. With origins dating back to the 1980s, we have built an outstanding reputation for quality, service excellence and innovation. Today, we partner with biotech companies globally to accelerate the development of new medicines.